Quantum Cyber N.V. Adjustments For Decrease Increase In Trade And Other Receivables
Quantum Cyber N.V. (QUCY) reported Adjustments For Decrease Increase In Trade And Other Receivables of -$100.35 thousand for the 6-month period ending 2025-06-30, per its 6-K filed 2025-09-26.
Financial Statements › Notes › Receivables
ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables · last filed 2025-09-26
- Quantum Cyber N.V. adjustments for decrease increase in trade and other receivables for the quarter ending 2023-06-30 was $31.24K, a 77.21% decline year-over-year.
- Quantum Cyber N.V. adjustments for decrease increase in trade and other receivables for the quarter ending 2023-03-31 was $27.66K.
- Quantum Cyber N.V. adjustments for decrease increase in trade and other receivables for the quarter ending 2022-06-30 was $137.06K.
- Quantum Cyber N.V. adjustments for decrease increase in trade and other receivables for the quarter ending 2022-03-31 was -$184.43K.
| Period end | Adjustments For Decrease Increase In Trade And Other Receivables 3 month | Adjustments For Decrease Increase In Trade And Other Receivables 6 month | Adjustments For Decrease Increase In Trade And Other Receivables 12 month |
|---|---|---|---|
| 2025-06-30 | -$100.35K 6-K · filed 2025-09-26 | ||
| 2024-12-31 | $64.28K 20-F · filed 2025-03-31 | ||
| 2024-06-30 | -$64.95K 6-K · filed 2025-09-26 | ||
| 2023-12-31 | $15.54K 20-F · filed 2025-03-31 | ||
| 2023-06-30 | $31.24K derived: 6-K 6 month − 6-K 3 month · filed 2024-10-18 | $58.90K 6-K · filed 2024-10-18 | |
| 2023-03-31 | $27.66K 6-K · filed 2023-05-16 | ||
| 2022-12-31 | -$211.23K 20-F · filed 2025-03-31 | ||
| 2022-06-30 | $137.06K derived: 6-K 6 month − 6-K 3 month · filed 2023-08-15 | -$47.37K 6-K · filed 2023-08-15 | |
| 2022-03-31 | -$184.43K 6-K · filed 2023-05-16 | ||
| 2021-12-31 | $24.21K 20-F · filed 2024-04-09 | ||
| 2021-06-30 | -$32.33K 6-K · filed 2022-09-07 | ||
| 2020-12-31 | -$99.15K 20-F · filed 2023-04-07 | ||
| 2019-12-31 | $339.62K 20-F · filed 2022-05-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |